Where has the time gone? We are now in 2025, and industry events are quickly approaching. If you are still gathering your thoughts on how best to maximise your events calendar this year, allow us to flag some of the ‘must-attend’ Healthcare conferences of Winter/Spring 2025. January is for JPM The 43rd JPM Annual Healthcare […]
Ottimo Pharma, a private biotech company pioneering bifunctional medicines to extend the lives of people living with cancer, on Thursday announced the completion of a Series A financing round of over $140 million. The financing will accelerate the lead asset, Jankistomig, a first-in-class PD1/VEGFR2 bifunctional antibody for multiple solid tumour indications, in both IV and […]
It’s been a busy week for Optimum, with some amazing original content from our clients, with this week’s podcast highlighting their expertise in cutting-edge lung cancer research. In our weekly hot topic article, they give predictions for the 2025 outlook following November’s London Life Sciences Week. We also have five clients nominated for the prestigious […]
Will we see you there? The Optimum team has taken a moment to map out the top life science conferences to attend in the next six months. Believe it or not, now is the time to be organising your 2025 conference calendar to maximise the opportunities these major life sciences events present. Secure your travel […]
Seasoned investor with 20 years of experience and a strong track record strengthens VC’s leadership in early-stage life science investments PARIS, France – September 10, 2024 — Sofinnova Partners (“Sofinnova”), a leading European venture capital firm in life sciences, based in Paris, London, and Milan, announced the appointment of Karl Naegler as Partner. This strategic hire also […]
